The upregulated expression of miR-21 has been connected to poor clinical outcome, and recent functional studies have demonstrated that miR-21 promotes tumor cell proliferation and invasion by targeting tumor suppressors PIK3R1 and PTEN [45,46,47,48]. The gene discussed is PTEN; the disease is neoplasm.